Form 4: Roivant Sciences CFO Richard Pulik Disposes of Shares for Tax Withholding

Roivant Sciences Ltd. CFO Richard Pulik reported the disposition of 1,503 common shares at $11.45 each, primarily for tax withholding obligations related to vested Restricted Stock Units (RSUs).

Summary

• Richard Pulik, Chief Financial Officer (CFO) of Roivant Sciences Ltd. (ROIV), reported a transaction on June 20, 2025.
• The transaction involved the disposition of 1,503 common shares.
• The shares were disposed of at a price of $11.45 per share.
• This disposition was a 'net settlement' by the Issuer to satisfy applicable tax withholding obligations in connection with the vesting and settlement of previously granted Restricted Stock Units (RSUs).
• Following this transaction, Richard Pulik beneficially owns 399,056 common shares directly.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a routine, non-discretionary disposition of shares for tax purposes related to RSU vesting, rather than a discretionary sale or purchase indicating a change in management's outlook.

Positives

• The transaction is a routine 'net settlement' for tax purposes, indicating the vesting of previously granted Restricted Stock Units (RSUs) to the CFO, which is a common form of executive compensation.

Negatives

• The disposition of shares, while for tax purposes, reduces the direct shareholding of a key executive, though this is a non-discretionary sale.

Future Outlook

The document does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This Form 4 filing is a standard disclosure of an insider transaction, specifically a non-discretionary sale of shares to cover tax obligations related to RSU vesting. Such transactions are common across all industries, particularly in companies that utilize equity-based compensation for executives.

Related Party Transactions

• The transaction involves the disposition of shares by a corporate officer (CFO) to the issuer for tax withholding purposes, which is a common type of insider transaction.

Stakeholder Impact

• Shareholders: The disposition of a small number of shares by the CFO for tax purposes is unlikely to have a significant impact on the company's stock price or shareholder value.
• Employees: The transaction highlights the use of equity compensation (RSUs) for executives, which is a common practice that aligns executive interests with shareholder value.

Key Dates

Keywords

Roivant Sciences, ROIV, Richard Pulik, CFO, SEC Form 4, Insider Transaction, Share Disposition, Tax Withholding, Restricted Stock Units, RSUs, Executive Compensation